-transparent.png){kind=logo}
A new antimicrobial drug combination of trimethoprim and methenamine hippurate (TMP + MH) at 2 different dosages (100 + 500 mg and 200 + 1000 mg b.i.d.) was compared by a random double-blind technique with plain TMP (200 mg b.i.d.) and TMP-sulfamethoxazole combination (160 mg + 800 mg b.i.d.). Each of the 4 test groups of 40-47 patients with acute UTI was treated for 2 weeks. The successful response in the test groups varied from 91 to 98% and no statistical difference could be found between the groups. The side-effects were least common in the group treated with the lower dose of TMP-MH combination.
Related Publications
J Seppänen, and
T Sulkava, and
T Vaalasti, and
H Korhonen, and
S Räisänen, and
P Ylitalo
January 1985,
Scandinavian journal of infectious diseases,
J Seppänen, and
T Sulkava, and
T Vaalasti, and
H Korhonen, and
S Räisänen, and
P Ylitalo
July 1976,
ZFA. Zeitschrift fur Allgemeinmedizin,
J Seppänen, and
T Sulkava, and
T Vaalasti, and
H Korhonen, and
S Räisänen, and
P Ylitalo
October 1974,
Annals of clinical research,
J Seppänen, and
T Sulkava, and
T Vaalasti, and
H Korhonen, and
S Räisänen, and
P Ylitalo
October 2007,
The Cochrane database of systematic reviews,
J Seppänen, and
T Sulkava, and
T Vaalasti, and
H Korhonen, and
S Räisänen, and
P Ylitalo
January 2002,
The Cochrane database of systematic reviews,
J Seppänen, and
T Sulkava, and
T Vaalasti, and
H Korhonen, and
S Räisänen, and
P Ylitalo
October 2012,
The Cochrane database of systematic reviews,
J Seppänen, and
T Sulkava, and
T Vaalasti, and
H Korhonen, and
S Räisänen, and
P Ylitalo
June 1967,
The Journal of urology,
J Seppänen, and
T Sulkava, and
T Vaalasti, and
H Korhonen, and
S Räisänen, and
P Ylitalo
December 1973,
Lakartidningen,
J Seppänen, and
T Sulkava, and
T Vaalasti, and
H Korhonen, and
S Räisänen, and
P Ylitalo
January 1970,
The Medical journal of Australia,
J Seppänen, and
T Sulkava, and
T Vaalasti, and
H Korhonen, and
S Räisänen, and
P Ylitalo
July 1978,
The Journal of antimicrobial chemotherapy,
